| HOME | MEETINGS | MEMBERSHIP | EXHIBITORS | AWARDS | INFO | NEWS | ABOUT US | CONTACT | SIGN IN |
ensuring knowledge, enhancing quality
A 'not-for-profit' organisation,
run for pharmaceutical analysts by pharmaceutical analysts
MEETINGS
Listed below are the future JPAG meetings and selected partner meetings.
For past meetings or info on invoices, venue, posters & CPD, see right.
For past meetings or info on invoices, venue, posters & CPD, see right.
Thursday 7th December 2023
Regulatory Hot Topics VIII
Royal Society of Chemistry, London
This symposium will address an introduction to the issues and challenges associated with use of biowaivers. Additional topics will cover UK and international Recognition & Reliance regulatory procedures as well as updated, new and emerging ICH guidance from 2023 and a look forward into 2024.
The meeting provides an excellent opportunity for dialogue, discussion and debate in an open forum and allows learning from expert speakers involved in the development of guidance and best practice.
The event will be in-person only, at RSC, London.
Speakers:
Rabiea Abdullah - Consultant
Dr Leonard Both - MHRA
Neil Clayton - Pfizer
Peter Crowley - MHRA
Dr Helena Engman - AstraZeneca
Dr Lisa Hinchliffe - Regulatory CMC Consultant
Dr Adele Patterson - Bristol-Myers Squibb
Dr Melanie Pires - Senior Consultant, NDA Group
Priti Shah - AstraZeneca
DETAILS AND REGISTRATION DOWNLOAD BROCHURE
Regulatory Hot Topics VIII
Royal Society of Chemistry, London
This symposium will address an introduction to the issues and challenges associated with use of biowaivers. Additional topics will cover UK and international Recognition & Reliance regulatory procedures as well as updated, new and emerging ICH guidance from 2023 and a look forward into 2024.
The meeting provides an excellent opportunity for dialogue, discussion and debate in an open forum and allows learning from expert speakers involved in the development of guidance and best practice.
The event will be in-person only, at RSC, London.
Speakers:
Rabiea Abdullah - Consultant
Dr Leonard Both - MHRA
Neil Clayton - Pfizer
Peter Crowley - MHRA
Dr Helena Engman - AstraZeneca
Dr Lisa Hinchliffe - Regulatory CMC Consultant
Dr Adele Patterson - Bristol-Myers Squibb
Dr Melanie Pires - Senior Consultant, NDA Group
Priti Shah - AstraZeneca
DETAILS AND REGISTRATION DOWNLOAD BROCHURE
Thursday 25th January 2024
Oligonucleotides - Stuck in the middle with you
Royal Society of Chemistry, London
They aren’t quite big, but they’re certainly not small. As such oligonucleotides present a unique challenge to pharmaceutical scientists and engineers; as well as a massive opportunity.
JPAG and the APS Materials Science focus group will be working together to deliver a joint seminar which will address the discovery and manufacturing challenges of oligonucleotide processing, from the joint perspectives of small and large molecule analytics and materials science.
Split across two sessions (morning and afternoon) we will look at the unique challenges and massive opportunity of oligos through the lenses of small and large molecule approaches.
DETAILS AND REGISTRATION DOWNLOAD BROCHURE
Oligonucleotides - Stuck in the middle with you
Royal Society of Chemistry, London
They aren’t quite big, but they’re certainly not small. As such oligonucleotides present a unique challenge to pharmaceutical scientists and engineers; as well as a massive opportunity.
JPAG and the APS Materials Science focus group will be working together to deliver a joint seminar which will address the discovery and manufacturing challenges of oligonucleotide processing, from the joint perspectives of small and large molecule analytics and materials science.
Split across two sessions (morning and afternoon) we will look at the unique challenges and massive opportunity of oligos through the lenses of small and large molecule approaches.
DETAILS AND REGISTRATION DOWNLOAD BROCHURE
Thursday 21st March 2024
Considering the raw materials: API & Excipients
Royal Society of Chemistry, London
Raw materials, APIs and excipients play an important role in the manufacturing of pharmaceutical products therefore it is important to assess and monitor quality of these materials throughout the product lifecycle. This symposium will present an overview of testing and risk assessment of these pharmaceutical product components throughout the life cycle with presentations and a panel discussion covering topics related to our key themes below:
- pharmacopoeial monographs for assessing raw materials
- regulatory perspectives (ICH Q7, ICH Q11) covering aspects for small molecules, biologics and ATMPs
- risk assessment of raw materials
- Good Manufacturing Practice
- physical testing including incoming receipt of API & excipients
- method optimisation and development
- stability of APIs
- supply chain impact & resilience
- sustainability
The meeting is open to the submission of "poster abstracts for Mar-24" and "questions for the Mar-24 panel" in line with the above proposed key themes, as per our guidance on the information page.
DETAILS AND REGISTRATION
Considering the raw materials: API & Excipients
Royal Society of Chemistry, London
Raw materials, APIs and excipients play an important role in the manufacturing of pharmaceutical products therefore it is important to assess and monitor quality of these materials throughout the product lifecycle. This symposium will present an overview of testing and risk assessment of these pharmaceutical product components throughout the life cycle with presentations and a panel discussion covering topics related to our key themes below:
- pharmacopoeial monographs for assessing raw materials
- regulatory perspectives (ICH Q7, ICH Q11) covering aspects for small molecules, biologics and ATMPs
- risk assessment of raw materials
- Good Manufacturing Practice
- physical testing including incoming receipt of API & excipients
- method optimisation and development
- stability of APIs
- supply chain impact & resilience
- sustainability
The meeting is open to the submission of "poster abstracts for Mar-24" and "questions for the Mar-24 panel" in line with the above proposed key themes, as per our guidance on the information page.
DETAILS AND REGISTRATION
Thursday 16th May 2024
Paediatrics Formulation
Royal Society of Chemistry, London
Development of paediatric formulations is linked to many challenges related to safety, efficacy, acceptability and patient adherence. The latter is a major challenge often dismissed in studies that particularly focus on the safety and efficacy of medicines. In addition, adherence can vary depending on the formulation and route of administration e.g. oral, parenteral, inhalation, etc…
This symposium focuses on integrated approaches across academia and industry to address challenges in the development, safety and efficacy of paediatric formulations and may include the key themes below:
- Safety of excipients in paediatric formulations
- Age appropriate formulations
- Challenges in paediatric drug delivery and clinical trials
- Advances in oral paediatric medicines (e.g. 3D printed tablets, Alder Hey teddy bear tabs, minitabs)
- Novel drug delivery devices
- Formulation development and characterisation of paediatric formulations
- Analysis of yet smaller levels of analytes and impurities
- Taste assessment of formulation: acceptability versus safety
- Invitro testing using robotic devices
- Inhalation devices for paediatrics
The meeting is open to the submission of abstracts for oral presentations or posters in line with the above proposed key themes.
DETAILS AND REGISTRATION
Paediatrics Formulation
Royal Society of Chemistry, London
Development of paediatric formulations is linked to many challenges related to safety, efficacy, acceptability and patient adherence. The latter is a major challenge often dismissed in studies that particularly focus on the safety and efficacy of medicines. In addition, adherence can vary depending on the formulation and route of administration e.g. oral, parenteral, inhalation, etc…
This symposium focuses on integrated approaches across academia and industry to address challenges in the development, safety and efficacy of paediatric formulations and may include the key themes below:
- Safety of excipients in paediatric formulations
- Age appropriate formulations
- Challenges in paediatric drug delivery and clinical trials
- Advances in oral paediatric medicines (e.g. 3D printed tablets, Alder Hey teddy bear tabs, minitabs)
- Novel drug delivery devices
- Formulation development and characterisation of paediatric formulations
- Analysis of yet smaller levels of analytes and impurities
- Taste assessment of formulation: acceptability versus safety
- Invitro testing using robotic devices
- Inhalation devices for paediatrics
The meeting is open to the submission of abstracts for oral presentations or posters in line with the above proposed key themes.
DETAILS AND REGISTRATION
Thursday 11th July 2024
Laboratories of the Future
Royal Society of Chemistry, London
The integration of the pharmaceutical industry with Industry 4.0 boosted pharmaceutical development that became digitised and has connected industry in all aspects related to manufacturing, product development and testing. As such automation, robotics, big data and machine learning have become key players in the pharmaceutical product lifecycle. This symposium will highlight the advancement of laboratories in terms of quality and efficiency in Industry 4.0 relating to automation, artificial intelligence, big data, blockchain and robotics.
Key themes could include:
- Evolution of pharmaceutical processes from industry 1.0 to 4.0
- Smart manufacturing systems: Pros and Cons
- Enhancing pre-clinical and clinical studies with artificial intelligence
- Fundamentals of in silico testing
- Managing analytical workflow in digital laboratories
- Role of click chemistry in product development
- Robot arms in sample preparation and measurement
- Use of analytical software in Smart Phone Apps
- Machine learning and Artificial Intelligent for analysis of pharmaceutical data
- Development of biomarkers for monitoring human health
- Personalised medicines and dosage forms
- Sustainability – not fully embedded? Driver for change?
The meeting is open to the submission of abstracts for oral presentations or posters in line with the above proposed key themes.
DETAILS AND REGISTRATION
Laboratories of the Future
Royal Society of Chemistry, London
The integration of the pharmaceutical industry with Industry 4.0 boosted pharmaceutical development that became digitised and has connected industry in all aspects related to manufacturing, product development and testing. As such automation, robotics, big data and machine learning have become key players in the pharmaceutical product lifecycle. This symposium will highlight the advancement of laboratories in terms of quality and efficiency in Industry 4.0 relating to automation, artificial intelligence, big data, blockchain and robotics.
Key themes could include:
- Evolution of pharmaceutical processes from industry 1.0 to 4.0
- Smart manufacturing systems: Pros and Cons
- Enhancing pre-clinical and clinical studies with artificial intelligence
- Fundamentals of in silico testing
- Managing analytical workflow in digital laboratories
- Role of click chemistry in product development
- Robot arms in sample preparation and measurement
- Use of analytical software in Smart Phone Apps
- Machine learning and Artificial Intelligent for analysis of pharmaceutical data
- Development of biomarkers for monitoring human health
- Personalised medicines and dosage forms
- Sustainability – not fully embedded? Driver for change?
The meeting is open to the submission of abstracts for oral presentations or posters in line with the above proposed key themes.
DETAILS AND REGISTRATION
EXTERNAL EVENTS:
UKCPA EVENTS:
See www.ukclinicalpharmacy.org for details.
Respiratory Pharmacy Conference 2024:
See HERE for details.
UKCPA EVENTS:
See www.ukclinicalpharmacy.org for details.
Respiratory Pharmacy Conference 2024:
See HERE for details.
INTERESTED IN OUR EVENTS?
We will keep you informed...
We will keep you informed...
All JPAG-hosted meetings award 4 hours of CPD points.
INVOICES & RECEIPTS are available: Please see the e-mail you receive after registration.
LOOKING FOR YOUR EVENT TICKET? Please see the e-mail you receive after registration.
VENUE INFORMATION
PRESENTING A POSTER?
INVOICES & RECEIPTS are available: Please see the e-mail you receive after registration.
LOOKING FOR YOUR EVENT TICKET? Please see the e-mail you receive after registration.
VENUE INFORMATION
PRESENTING A POSTER?
We always seek feedback from delegates attending JPAG events through an Evaluation form.
A recent analysis of the results has shown that more than 95% of attendees thought that JPAG meetings were well planned, relevant and met their main objectives, and would recommend JPAG meetings to colleagues
TESTIMONIALS...
Very enjoyable and thought-provoking day; going away with plenty of notes and specific items for discussion.
Excellent meeting, challenging and thought provoking. The organisation was excellent, thanks to all the efforts that JPAG team have made.
I have not attended a bad JPAG meeting yet. They are really good value for money and I really love to get the presentations as PDFs
I did appreciate receiving the slides before, as then I could print them and make notes around them during the symposium.
Getting an industry perspective on this topic was most helpful.
I appreciate having access to relevant JPAG seminars from overseas; provision of lectures beforehand to allow reading beforehand.
I did like having the presentations available early, with the webinar portion being focused on Q&A.
Fantastic to hear from NHS speaker, provides real insight to patient/clinician considerations that we don't necessarily see in industry.
From attendee perspective, the course did not take up the whole day as no travel necessary and overall good value for money.
Hearing the information from the clinical setting side was very useful.
Well organized. This was an amazing session. Prior sharing of the presentation was a great add on!
The most useful aspect of the webinar was the variety in the presentations across industry and the regulators. Really good to review the presentations beforehand.
Good value, well organised symposium. Always useful for focused topics.
A very good day. Enjoyed getting to speak to the presenters to discuss current challenges in industry.
Well done to all the speakers and the organisers for being able to successfully hold highly informative conferences virtually! (July 2020)
Very enjoyable and thought-provoking day; going away with plenty of notes and specific items for discussion.
Excellent meeting, challenging and thought provoking. The organisation was excellent, thanks to all the efforts that JPAG team have made.
I have not attended a bad JPAG meeting yet. They are really good value for money and I really love to get the presentations as PDFs
I did appreciate receiving the slides before, as then I could print them and make notes around them during the symposium.
Getting an industry perspective on this topic was most helpful.
I appreciate having access to relevant JPAG seminars from overseas; provision of lectures beforehand to allow reading beforehand.
I did like having the presentations available early, with the webinar portion being focused on Q&A.
Fantastic to hear from NHS speaker, provides real insight to patient/clinician considerations that we don't necessarily see in industry.
From attendee perspective, the course did not take up the whole day as no travel necessary and overall good value for money.
Hearing the information from the clinical setting side was very useful.
Well organized. This was an amazing session. Prior sharing of the presentation was a great add on!
The most useful aspect of the webinar was the variety in the presentations across industry and the regulators. Really good to review the presentations beforehand.
Good value, well organised symposium. Always useful for focused topics.
A very good day. Enjoyed getting to speak to the presenters to discuss current challenges in industry.
Well done to all the speakers and the organisers for being able to successfully hold highly informative conferences virtually! (July 2020)
JPAG plans and delivers events that address all aspects of pharmaceutical analysis and related facets of medicine control & registration.
PAST MEETINGS
Delegates at a symposium held at the Royal Society of Chemistry
| Call us: | CONTACT US | Follow us: |     | Terms and Conditions Privacy Statement |
| Joint Pharmaceutical Analysis Group 2023 Website © and by Delta Consultancy Services |
|